For global access to anti-infectious drugs

Bernard Pécoul is a physician, former President of MSF, and current Director of DNDi, a consortium based on a public-private partnership dedicated to the therapeutic management of neglected tropical infections. This partnership involves pharmaceutical companies making available or re-launching the development of molecules active against pathogens responsible for endemic parasitic diseases that remain of great concern, such as sleeping sickness caused by the inoculation of humans with the trypanosome parasite. Only this type of partnership currently seems capable of launching genuine campaigns to eradicate neglected tropical infections. DNDi is a model of its kind.